R&D Partner Content Welcome to the 3rd Spatial Biology for Drug Development Summ... Transforming Research & Development with Faster, More Precise Spatial Insights
Partner Content Partner Content 2nd Hit ID Summit Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.
R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
Market Access Partner Content The Inaugural Market Access for CNS Therapeutics Summit Has ... The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...
Partner Content Partner Content 5th Oligonucleotides for CNS Summit The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism
R&D Partner Content 2nd ADC & Novel Conjugates Partnering & Investment Summit Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
